Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family.

Hallowell N, Arden-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M.

Sociol Health Illn. 2006 Nov;28(7):969-88.

2.

Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.

Lodder L, Frets PG, Trijsburg RW, Tibben A, Meijers-Heijboer EJ, Duivenvoorden HJ, Wagner A, van Der Meer CA, Devilee P, Cornelisse CJ, Niermeijer MF.

Eur J Hum Genet. 2001 Jul;9(7):492-500.

3.

Men's decision-making about predictive BRCA1/2 testing: the role of family.

Hallowell N, Ardern-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M.

J Genet Couns. 2005 Jun;14(3):207-17. Review.

PMID:
15959652
4.
5.

Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems.

Hallowell N, Ardern-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M.

Clin Genet. 2005 Jun;67(6):492-502.

PMID:
15857416
6.

Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.

Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson M.

Soc Sci Med. 2004 Aug;59(3):553-65.

PMID:
15144764
7.

Men in the women's world of hereditary breast and ovarian cancer--a systematic review.

Strømsvik N, Råheim M, Oyen N, Gjengedal E.

Fam Cancer. 2009;8(3):221-9. doi: 10.1007/s10689-009-9232-1. Epub 2009 Jan 23.

PMID:
19165626
8.

Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.

Hamann HA, Croyle RT, Venne VL, Baty BJ, Smith KR, Botkin JR.

Am J Med Genet. 2000 May 1;92(1):25-32.

PMID:
10797419
9.

BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation.

Vaidyanathan K, Lakhotia S, Ravishankar HM, Tabassum U, Mukherjee G, Somasundaram K.

J Biosci. 2009 Sep;34(3):415-22.

10.

BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.

Ratajska M, Brozek I, Senkus-Konefka E, Jassem J, Stepnowska M, Palomba G, Pisano M, Casula M, Palmieri G, Borg A, Limon J.

Oncol Rep. 2008 Jan;19(1):263-8.

PMID:
18097605
11.

BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer.

Kessler L, Domchek S, Stopfer J, Halbert CH.

Community Genet. 2008;11(4):193-200. doi: 10.1159/000116879. Epub 2008 Apr 14.

PMID:
18417966
12.

Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group.

J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.

PMID:
18957670
13.

Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives.

Cypowyj C, Eisinger F, Huiart L, Sobol H, Morin M, Julian-Reynier C.

Psychooncology. 2009 Feb;18(2):209-15. doi: 10.1002/pon.1407.

PMID:
19061202
14.

Benefit finding in response to BRCA1/2 testing.

Low CA, Bower JE, Kwan L, Seldon J.

Ann Behav Med. 2008 Feb;35(1):61-9. doi: 10.1007/s12160-007-9004-9. Epub 2008 Feb 15.

PMID:
18347905
15.

Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.

Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, Rosen B, Murphy J, Elit L, Sun P, Narod S.

Clin Genet. 2009 Mar;75(3):220-4.

PMID:
19263514
16.

Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.

Suthers GK.

ANZ J Surg. 2007 May;77(5):314-9.

PMID:
17497966
17.

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.

Thomassen M, Hansen TV, Borg A, Lianee HT, Wikman F, Pedersen IS, Bisgaard ML, Nielsen FC, Kruse TA, Gerdes AM.

Acta Oncol. 2008;47(4):772-7. doi: 10.1080/02841860802004974.

PMID:
18465347
18.

The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.

Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, Sánchez-de-Abajo A, Caldés T, Blanco A, Graña B, Durán M, Velasco E, Chirivella I, Cardeñosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martínez E, Guillén C, Salazar R, San Román C, Antoniou AC, Urioste M, Benítez J.

Clin Cancer Res. 2008 May 1;14(9):2861-9. doi: 10.1158/1078-0432.CCR-07-4436.

19.

Familial effects of BRCA1 genetic mutation testing: changes in perceived family functioning.

Stroup AM, Smith KR.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):135-41.

20.

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Rebbeck TR, Domchek SM.

Breast Cancer Res. 2008;10(4):108. doi: 10.1186/bcr2115. Epub 2008 Jul 25.

Supplemental Content

Support Center